Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
SELECT MEDICAL HOLDINGS CORP (SEM)
|
|
Income Statement |
Business |
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 8-K | 10-K | 8-K | 10-Q | 10-Q | 10-K | 8-K |
Revenues: |
Concentra | 467.1 | | | | 441.4 | 423.4 | | |
Outpatient Rehabilitation | 303.0 | | | | 287.3 | 271.9 | | |
Other | 88.5 | | | | 81.3 | 81.8 | | |
Other | 815.9 | | | | 774.8 | 822.4 | | |
Total revenues | 1,674.5 | 1,665.0 | | 1,567.8 | 1,584.7 | 1,599.5 | | 1,534.2 |
Revenue growth [+] | 5.7% | 4.1% | | 2.2% | 1.3% | 3.4% | | 7.8% |
Concentra | 5.8% | | | | -3.3% | 0.1% | | |
Outpatient Rehabilitation | 5.5% | | | | 2.4% | 7.9% | | |
Other | 8.9% | | | | 15.3% | 18.6% | | |
Cost of goods sold | 1,422.9 | 1,418.8 | | 1,402.3 | 1,375.4 | 1,407.0 | | 1,299.4 |
Gross profit | 251.7 | 246.2 | | 165.5 | 209.3 | 192.5 | | 234.8 |
Gross margin | 15.0% | 14.8% | | 10.6% | 13.2% | 12.0% | | 15.3% |
Selling, general and administrative [+] | 42.5 | 42.3 | | 39.5 | 37.3 | 37.5 | | 37.9 |
General and administrative | 42.5 | 42.3 | | 39.5 | 37.3 | 37.5 | | 37.9 |
Equity in earnings | 10.5 | 8.6 | | 8.1 | 6.2 | 5.4 | | 11.5 |
Other operating expenses | | | | -16.9 | | | | -3.5 |
Adjusted EBITDA | 230.0 | 222.6 | | 41.3 | 187.2 | 169.2 | | 105.6 |
Adjusted EBITDA margin | 13.7% | 13.4% | | 2.6% | 11.8% | 10.6% | | 6.9% |
Stock-based compensation | 10.3 | 10.2 | 27.6 | -7.6 | 8.9 | 8.8 | 22.7 | -5.6 |
EBITDA [+] | 219.6 | 212.4 | | 48.9 | 178.2 | 160.4 | | 111.3 |
EBITDA growth | 23.2% | 32.4% | | -56.1% | -48.6% | -38.7% | | -48.3% |
EBITDA margin | 13.1% | 12.8% | | 3.1% | 11.2% | 10.0% | | 7.3% |
Depreciation | 49.9 | 52.4 | | -50.7 | 43.5 | 43.4 | | -50.4 |
EBITA | 169.7 | 160.0 | | 99.6 | 134.7 | 117.0 | | 161.7 |
EBITA margin | 10.1% | 9.6% | | 6.3% | 8.5% | 7.3% | | 10.5% |
Amortization of intangibles | | | | | 7.6 | 7.6 | | |
EBIT [+] | 169.7 | 160.0 | | 99.6 | 127.1 | 109.4 | | 161.7 |
EBIT growth | 33.5% | 46.3% | | -38.4% | -57.0% | -48.4% | | -1.9% |
EBIT margin | 10.1% | 9.6% | | 6.3% | 8.0% | 6.8% | | 10.5% |
Interest expense | 49.0 | 48.6 | | 45.2 | 41.1 | 35.5 | | 33.8 |
Interest expense | 49.0 | 48.6 | | 45.2 | 41.1 | 35.5 | | 33.8 |
Pre-tax income | 120.7 | 111.4 | | 54.3 | 86.1 | 73.9 | | 127.9 |
Income taxes | 28.8 | 26.2 | | 16.2 | 19.8 | 17.9 | | 27.7 |
Tax rate | 23.9% | 23.5% | | 29.8% | 23.0% | 24.3% | | 21.6% |
Minority interest | 13.6 | 14.5 | | 11.0 | 11.1 | 6.8 | | 23.3 |
Net income | 78.2 | 85.3 | | 38.1 | 55.2 | 49.1 | | 100.2 |
Net margin | 4.7% | 5.1% | | 2.4% | 3.5% | 3.1% | | 6.5% |
|
Basic EPS [+] | $0.64 | $0.56 | | $0.21 | $0.44 | $0.38 | | $0.57 |
Growth | 44.3% | 47.1% | | -63.2% | -65.0% | -55.1% | | -3.8% |
Diluted EPS [+] | $0.64 | $0.56 | | $0.21 | $0.44 | $0.38 | | $0.57 |
Growth | 44.3% | 47.1% | | -63.2% | -65.0% | -55.1% | | -3.8% |
|
Dividends per share [+] | $0.13 | $0.10 | | | $0.13 | $0.13 | | |
Growth | 0.0% | -16.5% | | | 0.0% | | | |
|
Shares outstanding (basic) [+] | 122.6 | 152.2 | | 181.6 | 124.9 | 129.0 | | 175.8 |
Growth | -1.8% | 18.0% | | 3.3% | -4.2% | -1.0% | | 35.4% |
Shares outstanding (diluted) [+] | 122.6 | 152.2 | | 181.6 | 124.9 | 129.0 | | 175.8 |
Growth | -1.8% | 18.0% | | 3.3% | -4.2% | -1.0% | | 35.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|